Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
Minard V, Hartmann O, Peyroulet MC, Michon J, Coze C, Defachelle AS, Lejars O, Perel Y, Bergeron C, Boutard P, Leverger G, Stephan JL, Thyss A, Chastagner P, Couillault G, Devalck C, Lutz P, Mechinaud F, Millot F, Plantaz D, Rialland X, Rubie H.
Minard V, et al. Among authors: hartmann o.
Br J Cancer. 2000 Oct;83(8):973-9. doi: 10.1054/bjoc.2000.1412.
Br J Cancer. 2000.
PMID: 10993641
Free PMC article.
Clinical Trial.